We studied this in the context of aging and obesity due to our prior work linking NLRP3 inflammasome activation to metabolic inflammation in these conditions (28, 29) and our subsequent discovery that BHB inhibits the NLRP3 inflammasome (25, 26). Here, NLRP3 is linked to obesity disorder.